Skip to main content

Odonate Therapeutics, Inc.

ODTDelisted Jan 25, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001717452

Odonate Therapeutics, Inc. was delisted on Jan 25, 2022; its insiders filed their last Form 4 on Dec 10, 2021; 50 institutions reported holding it in 13F filings for Q4 2021, worth $32.7M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Odonate Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ODT: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders5850−8
Shares32.6M24.2M−8.38M (−25.7%)
Value$94.9M$32.7M−$62.2M (−65.5%)

New holders (11)

Institutions that held Odonate Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ODT in Q4 2021
InstitutionSharesValue% of portfolio
Prosight Management, LP298,900$404.0K0.27%
Bridgeway Capital Management, LLC235,000$317.0K0.01%
Verition Fund Management LLC75,061$101.0K0.00%
Point72 Asset Management, L.P.50,000$68.0K0.00%
New York Life Investments Alternatives22,931$31.0K0.02%
Jane Street Group, LLC13,801$19.0K0.00%
ExodusPoint Capital Management, LP12,108$16.0K0.00%
XTX Topco Ltd11,714$16.0K0.01%
FMR LLC2,000$3.00K0.00%
TD Waterhouse Canada Inc.1,265$1.82K0.00%
UBS Group AG299$00.00%

Sold out (19)

Institutions that held Odonate Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.